How to Provide Vascular Control of Splenic Artery Aneurysm? Report of Two Cases

Sponsor
Tecnologico de Monterrey (Other)
Overall Status
Completed
CT.gov ID
NCT04502147
Collaborator
(none)
1
1
29
1

Study Details

Study Description

Brief Summary

Spleen artery aneurysm represents the most common visceral aneurysm and the third most common splanchnic aneurysm. Most patients have no symptoms and are diagnosed as a part of other diagnostic focuses and examinations. The investigators present two patients with splenic artery aneurysms localized in the splenic hilum, who auspiciously undergo laparoscopic splenectomies with hem-o-lock clips in the vascular hilum without complications. These two cases showed that in addition to the numerous advantages of minimally invasive approaches, there is the possibility to improve laparoscopic technique in terms of safety and economic reasons by using hem - o - lock clips as a hemostatic technique securing the vascular elements of the splenic hilum.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic Splenectomy

Study Design

Study Type:
Observational
Actual Enrollment :
1 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
How to Provide Vascular Control of Splenic Artery Aneurysm? Report of Two Cases
Actual Study Start Date :
Jul 1, 2020
Actual Primary Completion Date :
Jul 30, 2020
Actual Study Completion Date :
Jul 30, 2020

Outcome Measures

Primary Outcome Measures

  1. Arterial Splenic Aneurysm [July 2020]

    Asses the splenic hilium after operating a splenic arterial aneurysm. It will be measure by the follow up of the patient, by consult and physical examination.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Adults patients (>18 year old) with splenic arterial aneurysms

Exclusion Criteria:

Patients younger than 18 years old. Patients without splenic arterial aneurysms

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tecnologico de Monterrey Monterrey. Nuevo Leon Mexico 64710

Sponsors and Collaborators

  • Tecnologico de Monterrey

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alejandro Ruiz Velasco Santacruz, Chief of Residents, Tecnologico de Monterrey
ClinicalTrials.gov Identifier:
NCT04502147
Other Study ID Numbers:
  • 168/7
First Posted:
Aug 6, 2020
Last Update Posted:
Aug 6, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 6, 2020